Correlation Between CRISPR Therapeutics and Royal Caribbean

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Royal Caribbean at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Royal Caribbean into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Royal Caribbean Cruises, you can compare the effects of market volatilities on CRISPR Therapeutics and Royal Caribbean and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Royal Caribbean. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Royal Caribbean.

Diversification Opportunities for CRISPR Therapeutics and Royal Caribbean

0.58

Correlation Coefficient

CRISPR Therapeutics  Royal Caribbean

Very weak diversification

The 3 months correlation between CRISPR and Royal is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Royal Caribbean Cruises in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royal Caribbean Cruises and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Royal Caribbean. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royal Caribbean Cruises has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Royal Caribbean go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Royal Caribbean

Assuming the 90 days trading horizon CRISPR Therapeutics is expected to generate 7.66 times less return on investment than Royal Caribbean. In addition to that, CRISPR Therapeutics is 1.45 times more volatile than Royal Caribbean Cruises. It trades about 0.02 of its total potential returns per unit of risk. Royal Caribbean Cruises is currently generating about 0.27 per unit of volatility. If you would invest  50,750  in Royal Caribbean Cruises on October 8, 2024 and sell it today you would earn a total of  19,483  from holding Royal Caribbean Cruises or generate 38.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.31%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Royal Caribbean Cruises

CRISPR Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Royal Caribbean Cruises

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Royal Caribbean Cruises are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Royal Caribbean sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CRISPR Therapeutics and Royal Caribbean

The main advantage of trading using opposite CRISPR Therapeutics and Royal Caribbean positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Royal Caribbean can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royal Caribbean will offset losses from the drop in Royal Caribbean's long position.

The idea behind CRISPR Therapeutics AG and Royal Caribbean Cruises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.